Graham Capital Management, L.P. Vir Biotechnology, Inc. Transaction History
Graham Capital Management, L.P.
- $4.42 Billion
- Q3 2024
A detailed history of Graham Capital Management, L.P. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 35,915 shares of VIR stock, worth $290,552. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,915
Previous 12,594
185.18%
Holding current value
$290,552
Previous $112,000
140.18%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIR
# of Institutions
219Shares Held
87.4MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$135 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$106 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$45.5 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$28.9 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.07B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...